阿加曲班在血液净化中的应用

被引:17
作者
肖青
孙雪峰
机构
[1] 解放军总医院、全军肾脏病研究所暨重点实验室
关键词
D O I
暂无
中图分类号
R973 [血液和造血系统药物];
学科分类号
100117 [系统生物医学];
摘要
<正>血液净化作为一种体外循环,抗凝治疗是其重要组成部分;因此寻找合适的抗凝剂一直是血液净化的重要课题。在凝血联级反应中,凝血酶是中心环节,有效抑制凝血酶是充分抗凝治疗的关键。凝血酶抑制剂分为间接凝血酶抑制剂和直接凝血酶抑制剂。由于普通肝素和低分子肝素等间接凝血酶抑制剂存在许多不足,因此直接凝血酶抑制剂成为近
引用
收藏
页码:223 / 225
页数:3
相关论文
共 4 条
[1]
Hydroxyethyl starch enhances argatroban-mediated decreases in clot propagation and strength by diminishing thrombin–fibrinogen interactions.[J].Vance G Nielsen;James K Kirklin.Blood Coagulation & Fibrinolysis.2007, 1
[2]
Direct thrombin inhibitors in cardiac disease [J].
Jeffrey I. Weitz ;
Eric R. Bates .
Cardiovascular Toxicology, 2003, 3 (1) :13-25
[3]
Clinical trial of argatroban, a direct thrombin inhibitor, as an anticoagulant in cardiopulmonary support and apheresis in emergency patients: A preliminary report [J].
Akashi K. ;
Masui Y. ;
Soma K. ;
Kawada T. ;
Takahashi Y. ;
Yamanaka I. ;
Inokuchi S. ;
Sugiyama M. .
Journal of Artificial Organs, 2002, 5 (4) :223-227
[4]
Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia [J].
Walenga, JM ;
Ahmad, S ;
Hoppensteadt, D ;
Iqbal, O ;
Hursting, MJ ;
Lewis, BE .
THROMBOSIS RESEARCH, 2002, 105 (05) :401-405